Physitrack (Interview): Growth returns; RTM live and the US offensive begins
Idag, 09:00
Idag, 09:00
Physitrack CEO Henrik Molin discusses the company's Q2 report, highlighting roughly 10% year-to-date growth and a seventh consecutive quarter of positive operating cash flow. He details the US launch of RTM (Remote Therapeutic Monitoring) — now live with one of the country's largest hospital systems and over 100 active sales discussions — the cross-sell potential between LifeCare and Champion Health under the new "Project Physia" initiative, and the company's new long-term incentive program aimed at attracting and retaining talent in the US market.
Idag, 09:00
Physitrack CEO Henrik Molin discusses the company's Q2 report, highlighting roughly 10% year-to-date growth and a seventh consecutive quarter of positive operating cash flow. He details the US launch of RTM (Remote Therapeutic Monitoring) — now live with one of the country's largest hospital systems and over 100 active sales discussions — the cross-sell potential between LifeCare and Champion Health under the new "Project Physia" initiative, and the company's new long-term incentive program aimed at attracting and retaining talent in the US market.
Kambis Q2-rapport
Aktieanalys

Rapporter i urval
Kambis Q2-rapport
Aktieanalys
Rapporter i urval
1 DAG %
Senast

OMX Stockholm 30
1,26%
(vid stängning)
Hacksaw
Idag, 13:31
Hacksaw: Täljer guld med smörkniv
OMX Stockholm 30
1 DAG %
Senast
3 186,12